| (USD) | Dec 2023 | Q/Q |
|---|---|---|
| Revenue | 258.8MM | -13% |
| Gross Profit | 105.4MM | -20% |
| Cost Of Revenue | 153.4MM | -8% |
| Operating Income | -23.4MM | -729% |
| Operating Expenses | 128.8MM | +0% |
| Net Income | -14.4MM | -359% |
| R&D | 26.8MM | +10% |
| G&A | 102MM | -2% |
| Amortization | 7.5MM | -3% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
FORT WORTH, Texas, April 16, 2024--Omnicell Announces XT Amplify: Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing System
Every investor on earth makes bad calls sometimes. But really big losses can really drag down an overall portfolio. So...
FORT WORTH, Texas, April 08, 2024--Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here. The Mid Company Fund returns of 14.08% in the quarter slightly lagged the 14.55% return for the Russell Midcap Growth Index. The fund declined 27.14% for […]
There are some great robotics stocks for investors to buy in the robotics industry. I feel that these companies have the most upside potential out of their competitors. The robotics industry is still in its infancy, and as technologies such as AI continue to be adopted worldwide, these firms could be the main beneficiaries of such a transition. The companies discussed in this article are on the cutting edge of robotics and AI integration. They are poised to capitalize on the rising demand for ad
FORT WORTH, Texas, March 11, 2024--Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum
Investors are optimistic about Omnicell (OMCL) moving closer to achieving its vision of Autonomous Pharmacy.
In this article, we will be taking a look at the 20 most valuable digital health companies in the US. If you are not interested in reading about the global health market, head straight to the 5 Most Valuable Digital Health Companies In The US. As of the latest data, several digital health companies stand […]
Omnicell's (OMCL) fourth-quarter 2023 performance favorably reflects a heightened focus on managing costs.
It's been a sad week for Omnicell, Inc. ( NASDAQ:OMCL ), who've watched their investment drop 14% to US$27.41 in the...